Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
about
A validated model of serum anti-müllerian hormone from conception to menopauseAntimüllerian hormone as a predictor of natural fecundability in women aged 30-42 yearsAnti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve MarkersThe ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingThe FMR1 gene, infertility, and reproductive decision-making: a reviewAdded value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approachFemale reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complicationsAnti-mullerian hormone as a predictor of time to menopause in late reproductive age womenImpact of cancer therapies on ovarian reserveLongitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial.Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 yearsAnti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundabilityBiologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in womenAntimullerian hormone and obesity: insights in oral contraceptive users.The Protective Effect of N-Acetylcysteine on Ionizing Radiation Induced Ovarian Failure and Loss of Ovarian Reserve in Female Mouse.Assay reproducibility and within-person variation of Müllerian inhibiting substance.Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndromeMaternal antimullerian hormone levels do not predict fetal aneuploidy.Regulation of anti-Müllerian hormone production in the cow: a multiscale study at endocrine, ovarian, follicular, and granulosa cell levels.Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance levelExecutive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.The role of anti-Müllerian hormone in female fertility and infertility - an overview.Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?Genetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African AmericansThe genetic make-up of ovarian development and function: the focus on the transcription factor FOXL2.Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.Reclaiming fertility awareness methods to inform timed intercourse for HIV serodiscordant couples attempting to conceiveThe reproductive endocrinology of the menopausal transition.Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected womenThe impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels.Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersTrisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile womenAnti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatmentAnti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.Serum antimüllerian hormone in healthy premenopausal women.It's Never over until It's over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH-A Study of 5069 Romanian WomenAn analysis of the influence of selected genetic and hormonal factors on the occurrence of depressive symptoms in late-reproductive-age women.
P2860
Q21135308-F85C1D2F-C914-4676-A8D9-E1C6CF5A6495Q23910016-75611CEC-ADAC-43E7-B462-D8F3F47188E7Q26765770-C27C4A9A-120E-4C77-8FD6-5B1A42135FE1Q27024729-832815EC-F7ED-47F1-A98D-C65F8A964545Q27026188-F3645A35-1649-4660-A2CC-6D2EE449E81BQ27026782-6082E107-FCB8-4642-B403-13B1C8F1150AQ28280088-52A615CE-3774-4BB8-BF5E-E747BC4AF51AQ28383280-F4FE19DE-6773-4077-B646-BDEB9127B9C7Q28383911-BF7B4BC8-BF46-4D60-89F0-F0306EDF15F9Q28384958-007ABE8E-66D2-4526-B9C9-E7D32F1FCE0AQ28388248-5AADD2AA-B02A-46D2-AA68-6BA6685B4AB5Q28391817-D593D7F6-9C14-4687-B272-6A6C25630ACCQ28395441-77792ED6-4423-42C8-8743-04BDA838B0F8Q28396276-E616016F-D9B3-434A-958A-3491055FA4CCQ30439646-B979744C-74B3-4878-B8EC-292F8EFD0D7BQ33669042-C609E10B-9DA7-4D24-95E8-9A6B600C3B43Q33760075-561F13C6-4B39-42B6-ABC1-2B9AFE0D214AQ33875907-96095779-8FD3-43FA-8B1E-D4D8DAA14946Q33917112-8BA2273E-B047-40B3-8318-EA3C8ADBAD5CQ34070204-61E02358-A690-4EA2-9499-45B771606A5FQ34149740-A28E02FB-F97D-4E8B-A640-327908AAA211Q34196639-47DA0ED1-AAE4-46CE-B32B-7519C4E63EEAQ34255040-514A51AC-9EEB-4C9D-BD7A-34D4C438AF1BQ34278051-14E96366-C29F-4B40-9EF6-CA2C84F49676Q34415976-73DF26D8-8A12-44DD-81D5-6AB59F54BDE4Q34426520-1DE5F5F0-AC2B-400C-921C-5840DB7E2F29Q34539732-019BCB24-C15E-4B12-8AAC-A78AE2C86E6DQ34568747-A3ED6CC6-0A89-4571-8DD5-780D1D635F86Q34902729-78E9CCCE-F638-4B8D-B5DF-28372396F56FQ35000332-8B08A25C-797C-4FB9-AE0D-7570B54E4FA3Q35070210-7392089C-3B08-41B8-863E-73D0FDA73A0AQ35102795-947B997A-E386-4C18-9713-56AA531B1CDEQ35108269-B8C68E1A-43A5-42C2-B9CB-91BD55E14E27Q35117692-8FD3BD57-C1B3-4827-824E-827316650EC1Q35166382-36CCCC68-B4AA-4D72-9499-6642A6C018D8Q35171104-D78EEDFE-5711-4B8D-8F75-A71CB8525EA1Q35181958-EC962FF0-2010-41A5-89EB-7964B88BCD43Q35185385-09F5E6C2-8414-42AE-9896-12168CB1B699Q35536572-35CB175C-D079-465C-B7A5-B175AC4E04E6Q35539680-6869782B-6765-40AE-A249-257C246B1A4D
P2860
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@ast
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@en
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@nl
type
label
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@ast
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@en
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@nl
prefLabel
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@ast
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@en
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@nl
P2093
P1476
Serum antimullerian hormone le ...... rtility: a longitudinal study.
@en
P2093
Axel P N Themmen
Bart J C M Fauser
Caspar W N Looman
Egbert R te Velde
Frank H de Jong
Frank J M Broekmans
Gabrielle J Scheffer
Ilse A J van Rooij
J Dik F Habbema
P304
P356
10.1016/J.FERTNSTERT.2004.11.029
P407
P577
2005-04-01T00:00:00Z